JUST IN: The FDA has approved donanemab, Eli Lilly's treatment for early Alzheimer's disease.
CNN’s Post
More Relevant Posts
-
Essay | Do People Want to Live Longer With Alzheimer's Disease? Check out this interesting article on Alzheimer's disease!
Essay | Do People Want to Live Longer With Alzheimer's Disease?
wsj.com
To view or add a comment, sign in
-
Essay | Do People Want to Live Longer With Alzheimer's Disease? Check out this interesting article on Alzheimer's disease!
Essay | Do People Want to Live Longer With Alzheimer's Disease?
wsj.com
To view or add a comment, sign in
-
The fight against Alzheimer's continues. Check out this 60 Minutes report on the new approaches to treating the disease: --- #PharmaceuticalIndustry #Pharma #Innovation #Alzheimers #SciSearch
The hope for early detection and prevention of Alzheimer's disease
cbsnews.com
To view or add a comment, sign in
-
A new age of Alzheimer's - a really timely report to browse as the APDD meeting (12th Alzheimer’s & Parkinson’s Drug Development Summit) organised by Hanson Wade Group is starting in Boston tomorrow! Christopher Cook and I will be there, give us a shout if you are around too! 👉 Currently, there are around 7 million Alzheimer's patients in the US alone. By 2050, this number is projected to rise to nearly 13 million (The lifetime risk for Alzheimer's at age 45 is 1 in 5 for women and 1 in 10 for men) 👉 We have made startling advances early Alzheimer’s disease detection, when treatments are most effective. 👉 Drugs are now available that can slow the progress of the disease, having gone from the lab to pharmacy shelves, and more are in the pipeline. https://lnkd.in/eQ5wYsXB
The New Age of Alzheimer’s
scientificamerican.com
To view or add a comment, sign in
-
Join me on April 23 to hear perspectives from top clinical research experts and disease area specialists on Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠 Learn about development challenges in each, how they were overcome, and the shared lessons that can propel novel approaches to more effective clinical trials. Register now to secure your spot and join in this innovative conversation! #Alzheimers #MultipleSclerosis #ClinicalTrials #Biotech
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives :: Parexel
share.parexel.social
To view or add a comment, sign in
-
Join me on April 23 to hear perspectives from top clinical research experts and disease area specialists on Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠 Learn about development challenges in each, how they were overcome, and the shared lessons that can propel novel approaches to more effective clinical trials. Register now to secure your spot and join in this innovative conversation! #Alzheimers #MultipleSclerosis #ClinicalTrials #Biotech
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives :: Parexel
share.parexel.social
To view or add a comment, sign in
-
Join me on April 23 to hear perspectives from top clinical research experts and disease area specialists on Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠 Learn about development challenges in each, how they were overcome, and the shared lessons that can propel novel approaches to more effective clinical trials. Register now to secure your spot and join in this innovative conversation! #Alzheimers #MultipleSclerosis #ClinicalTrials #Biotech
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives :: Parexel
share.parexel.social
To view or add a comment, sign in
-
Join me on April 23 to hear perspectives from top clinical research experts and disease area specialists on Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠 Learn about development challenges in each, how they were overcome, and the shared lessons that can propel novel approaches to more effective clinical trials. Register now to secure your spot and join in this innovative conversation! #Alzheimers #MultipleSclerosis #ClinicalTrials #Biotech
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives :: Parexel
share.parexel.social
To view or add a comment, sign in
-
Join me on April 23 to hear perspectives from top clinical research experts and disease area specialists on Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠 Learn about development challenges in each, how they were overcome, and the shared lessons that can propel novel approaches to more effective clinical trials. Register now to secure your spot and join in this innovative conversation! #Alzheimers #MultipleSclerosis #ClinicalTrials #Biotech
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives :: Parexel
share.parexel.social
To view or add a comment, sign in
-
Join me on April 23 to hear perspectives from top clinical research experts and disease area specialists on Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠 Learn about development challenges in each, how they were overcome, and the shared lessons that can propel novel approaches to more effective clinical trials. Register now to secure your spot and join in this innovative conversation! #Alzheimers #MultipleSclerosis #ClinicalTrials #Biotech
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives :: Parexel
share.parexel.social
To view or add a comment, sign in
3,098,972 followers